Dr. Gabriela Brumatti
Honorary
Medical Biology (w.e.h.i.)
44 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models
DOI: 10.1182/bloodadvances.20200015762020
Journal article
MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia
DOI: 10.1182/bloodadvances.20200027082020
Journal article
Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo
DOI: 10.3390/v120809012020
Journal article
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction
DOI: 10.1038/s41467-020-16819-z2020
Journal article
Future Therapeutic Directions for Smac-Mimetics
DOI: 10.3390/cells90204062019
Journal article
TARGETING MULTIDRUG RESISTANCE PROTEIN 1 (MDR1) POTENTIATES SMAC-MIMETIC THERAPY TO KILL LEUKEMIC STEM CELLS AND OVERCOME RESISTANCE IN ACUTE MYELOID LEUKEMIA
DOI: 10.1016/j.exphem.2019.06.4102017
Journal article
Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell death
DOI: 10.1002/prca.201700013
RECENT SCHOLARLY WORKS
2017
Journal article
High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression
DOI: 10.1182/bloodadvances.20160029312017
Journal article
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
DOI: 10.1016/j.molcel.2017.05.0032017
Journal article
DR5 and caspase-8 are dispensable in ER stress-induced apoptosis
DOI: 10.1038/cdd.2017.53